Medtronic plc, a global leader in healthcare technology, has announced the spin-off of its Diabetes business, which will operate under the historic name MiniMed. The decision pays homage to MiniMed's origins before being acquired by Medtronic in 2001. The new company, based in Northridge, California, comprises over 8,000 employees dedicated to innovating diabetes care. The separation is expected to be completed within 18 months, subject to customary conditions and legal requirements. The move aims to enhance focus on developing breakthrough technologies that improve quality of life and redefine diabetes care standards.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。